Tuberculosis remains a major public health challenge, as treatment requires a combination of antibiotics taken over several months and is becoming increasingly difficult due to the emergence of resistant strains. CSIR-CCMB uncovers critical TB protein secretion targets (SecA1, Tat) revealing new drug targets to combat drug-resistant tuberculosis.